9 employees
Nereid Therapeutics is discovering new disease treatments by applying research and technologies in biomolecular condensates.
2020
$50M
from 1 investors over 1 rounds
Nereid Therapeutics raised $50M on November 16, 2020
Investors: ATP (Apple Tree Partners)